Transtactin: A universal transmembrane delivery system for Strep-tag II-fused cargos

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 7, 2010, Pages 1935-1945

  Moosmeier, Markus A ^a   Bulkescher, Julia ^a   Reed, Jennifer ^a   Schnölzer, Martina ^a   Heid, Hans ^a   Hoppe Seyler, Karin ^a   Hoppe Seyler, Felix ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Biosafety; Drug delivery; Protein transduction; Streptavidin

Indexed keywords

MEMBRANE PROTEIN; STREPTOMYCIN;

ARTICLE; CELL LINE; HUMAN; METABOLISM;

CELL LINE; HUMANS; MEMBRANE PROTEINS; STREPTOMYCIN;

ARMORACIA RUSTICANA;

EID: 77955801243     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00846.x     Document Type: Article

References (53)

1. Qian ZM, Li H, Sun H. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev. 2002, 54:561-87.
2. Wileman T, Harding C, Stahl P. Receptor-mediated endocytosis. Biochem J. 1985, 232:1-14.
3. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 1988, 55:1189-93.
4. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell. 1988, 55:1179-88.
5. Fawell S, Seery J, Daikh Y. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA. 1994, 91:664-8.
6. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997, 272:16010-7.
7. Honda A, Moosmeier MA, Dostmann WR. Membrane-permeable cygnets: rapid cellular internalization of fluorescent cGMP-indicators. Front Biosci. 2005, 10:1290-301.
8. Derossi D, Joliot AH, Chassaing G. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem. 1994, 269:10444-50.
9. Mitchell DJ, Kim DT, Steinman L. Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res. 2000, 56:318-25.
10. Futaki S, Suzuki T, Ohashi W. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem. 2001, 276:5836-40.
11. Dietz GP, Bahr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci. 2004, 27:85-131.
12. Gump JM, Dowdy SF. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med. 2007, 13:443-8.
13. Trehin R, Merkle HP. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm. 2004, 58:209-23.
14. Park J, Ryu J, Jin LH. 9-polylysine protein transduction domain: enhanced penetration efficiency of superoxide dismutase into mammalian cells and skin. Mol Cells. 2002, 13:202-8.
15. Jin LH, Bahn JH, Eum WS. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic Biol Med. 2001, 31:1509-19.
16. Rothbard JB, Garlington S, Lin Q. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med. 2000, 6:1253-7.
17. Green NM. Avidin and streptavidin. Methods Enzymol. 1990, 184:51-67.
18. Mi Z, Mai J, Lu X. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol Ther. 2000, 2:339-47.
19. Mai JC, Shen H, Watkins SC. Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate. J Biol Chem. 2002, 277:30208-18.
20. Laitinen OH, Nordlund HR, Hytonen VP. Brave new (strept)avidins in biotechnology. Trends Biotechnol. 2007, 25:269-77.
21. Albarran B, To R, Stayton PS. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells. Protein Eng Des Sel. 2005, 18:147-52.
22. Rinne J, Albarran B, Jylhava J. Internalization of novel non-viral vector TAT-streptavidin into human cells. BMC Biotechnol. 2007, 7:1.
23. Futaki S, Niwa M, Nakase I. Arginine carrier peptide bearing Ni(II) chelator to promote cellular uptake of histidine-tagged proteins. Bioconjug Chem. 2004, 15:475-81.
24. Schmidt TG, Skerra A. The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins. Nat Protoc. 2007, 2:1528-35.
25. Voss S, Skerra A. Mutagenesis of a flexible loop in streptavidin leads to higher affinity for the Strep-tag II peptide and improved performance in recombinant protein purification. Protein Eng. 1997, 10:975-82.
26. Schmidt TG, Skerra A. One-step affinity purification of bacterially produced proteins by means of the "Strep tag" and immobilized recombinant core streptavidin. J Chromatogr A. 1994, 676:337-45.
27. Reed J, Reed TA. A set of constructed type spectra for the practical estimation of peptide secondary structure from circular dichroism. Anal Biochem. 1997, 254:36-40.
28. El-Andaloussi S, Jarver P, Johansson HJ. Cargo dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. Biochem J. 2007, 407:285-92.
29. Mogk A, Schmidt R, Bukau B. The N-end rule pathway for regulated proteolysis: prokaryotic and eukaryotic strategies. Trends Cell Biol. 2007, 17:165-72.
30. Sano T, Cantor CR. Intersubunit contacts made by tryptophan 120 with biotin are essential for both strong biotin binding and biotin-induced tighter subunit association of streptavidin. Proc Natl Acad Sci USA. 1995, 92:3180-4.
31. Waner MJ, Navrotskaya I, Bain A. Thermal and sodium dodecylsulfate induced transitions of streptavidin. Biophys J. 2004, 87:2701-13.
32. Bayer EA, Ehrlich-Rogozinski S, Wilchek M. Sodium dodecyl sulfate-polyacrylamide gel electrophoretic method for assessing the quaternary state and comparative thermostability of avidin and streptavidin. Electrophoresis. 1996, 17:1319-24.
33. Hyre DE, Le Trong I, Merritt EA. Cooperative hydrogen bond interactions in the streptavidin-biotin system. Protein Sci. 2006, 15:459-67.
34. Korndorfer IP, Skerra A. Improved affinity of engineered streptavidin for the Strep-tag II peptide is due to a fixed open conformation of the lid-like loop at the binding site. Protein Sci. 2002, 11:883-93.
35. Green NM, Melamed MD. Optical rotatory dispersion, circular dichroism and far-ultraviolet spectra of avidin and streptavidin. Biochem J. 1966, 100:614-21.
36. Grishina IB, Woody RW. Contributions of tryptophan side chains to the circular dichroism of globular proteins: exciton couplets and coupled oscillators. Faraday discussions. 1994, 245-62.
37. Mandal K, Bose SK, Chakrabarti B. Structure and stability of gamma-crystallins. I. Spectroscopic evaluation of secondary and tertiary structure in solution. Biochim Biophys Acta. 1985, 832:156-64.
38. Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev. 2005, 57:559-77.
39. Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med. 1987, 28:1294-302.
40. McMahan SA, Burgess RR. Single-step synthesis and characterization of biotinylated nitrilotriacetic acid, a unique reagent for the detection of histidine-tagged proteins immobilized on nitrocellulose. Anal Biochem. 1996, 236:101-6.
41. O'Shannessy DJ, O'Donnell KC, Martin J. Detection and quantitation of hexa-histidine-tagged recombinant proteins on western blots and by a surface plasmon resonance biosensor technique. Anal Biochem. 1995, 229:119-24.
42. Reichel A, Schaible D, Al Furoukh N. Noncovalent, site-specific biotinylation of histidine-tagged proteins. Anal Chem. 2007, 79:8590-600.
43. Sawyer CL, Honda A, Dostmann WR. Cygnets: spatial and temporal analysis of intracellular cGMP. Proc West Pharmacol Soc. 2003, 46:28-31.
44. Borghouts C, Kunz C, Groner B. Current strategies for the development of peptide-based anti-cancer therapeutics. J Pept Sci. 2005, 11:713-26.
45. Prive GG, Melnick A. Specific peptides for the therapeutic targeting of oncogenes. Curr Opin Genet Dev. 2006, 16:71-7.
46. Borghouts C, Kunz C, Delis N. Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition. Mol Cancer Res. 2008, 6:267-81.
47. Colas P. Combinatorial protein reagents to manipulate protein function. Curr Opin Chem Biol. 2000, 4:54-9.
48. Hoppe-Seyler F, Crnkovic-Mertens I, Tomai E. Peptide aptamers: specific inhibitors of protein function. Curr Mol Med. 2004, 4:529-38.
49. Fuchs SM, Raines RT. Polyarginine as a multifunctional fusion tag. Protein Sci. 2005, 14:1538-44.
50. Breitz HB, Weiden PL, Beaumier PL. Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin. J Nucl Med. 2000, 41:131-40.
51. Meyer DL, Schultz J, Lin Y. Reduced antibody response to streptavidin through site-directed mutagenesis. Protein Sci. 2001, 10:491-503.
52. Skerra A. Lipocalins as a scaffold. Biochim Biophys Acta. 2000, 1482:337-50.
53. Schlehuber S, Skerra A. Anticalins as an alternative to antibody technology. Expert Opin Biol Ther. 2005, 5:1453-62.